{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:05:18Z","timestamp":1765713918921},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00347-016-0368-8","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T02:54:12Z","timestamp":1474858452000},"page":"1010-1022","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thrombozytenaggregationshemmer und Antikoagulantien bei augenchirurgischen Eingriffen"],"prefix":"10.1007","volume":"113","author":[{"given":"N.","family":"Feltgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Noske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Koscielny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,26]]},"reference":[{"key":"368_CR1","volume-title":"Wei\u00dfbuch zur Situation der ophthalmologischen Versorgung in Deutschland","author":"C Wolfram","year":"2012","unstructured":"Wolfram C, Pfeiffer N (2012) Wei\u00dfbuch zur Situation der ophthalmologischen Versorgung in Deutschland. Deutsche Ophthalmologische Gesellschaft, M\u00fcnchen (65 p.)"},{"issue":"1","key":"368_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.eye.6703069","volume":"23","author":"JD Benzimra","year":"2009","unstructured":"Benzimra JD, Johnston RL, Jaycock P, Galloway PH, Lambert G, Chung AKK et\u00a0al (2009) The Cataract National Dataset electronic multicentre audit of 55,567 operations: Antiplatelet and anticoagulant medications. Eye (Lond) 23(1):10\u201316","journal-title":"Eye (Lond)"},{"issue":"10","key":"368_CR3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","volume":"17","author":"H Heidbuchel","year":"2015","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Diener H\u2011C, Hacke W et al (2015) Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17(10):1467\u20131507","journal-title":"Europace"},{"issue":"4","key":"368_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/ACO.0000000000000100","volume":"27","author":"G Breuer","year":"2014","unstructured":"Breuer G, Weiss DR, Ringwald J (2014) \u201cNew\u201d direct oral anticoagulants in the perioperative setting. Curr Opin Anaesthesiol 27(4):409\u2013419","journal-title":"Curr Opin Anaesthesiol"},{"issue":"3","key":"368_CR5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1160\/TH14-04-0305","volume":"113","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Healey JS, Brueckmann M, Eikelboom JW, Ezekowitz MD, Fraessdorf M et al (2015) Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost 113(3):625\u2013632","journal-title":"Thromb. Haemost."},{"issue":"6","key":"368_CR6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1160\/TH14-11-0954","volume":"113","author":"J Beyer-Westendorf","year":"2015","unstructured":"Beyer-Westendorf J, Ebertz F, F\u00f6rster K, Gelbricht V, Michalski F, K\u00f6hler C et al (2015) Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry. Thromb Haemost 113(6):1247\u20131257","journal-title":"Thromb. Haemost."},{"issue":"6","key":"368_CR7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/bja\/ael083","volume":"96","author":"MN Vicenzi","year":"2006","unstructured":"Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H (2006) Coronary artery stenting and non-cardiac surgery \u2013 a prospective outcome study. Br J Anaesth 96(6):686\u2013693","journal-title":"Br J Anaesth"},{"key":"368_CR8","unstructured":"Braun O, Erlinge D, Wallen H, Jeppson A, Svensson P, Sjalander A (2015) Clinical recommendations for surgery and bleeding during treatment with oral antiplatelet agents. Developed at the request of the Swedish Society of Cardiology and the Swedish Society on Thrombosis and Haemostasis"},{"issue":"12","key":"368_CR9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","volume":"27","author":"W Gogarten","year":"2010","unstructured":"Gogarten W, Vandermeulen E, Van Aken H, Kozek S, Llau JV, Samama CM et\u00a0al (2010) Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 27(12):999\u20131015","journal-title":"Eur J Anaesthesiol"},{"key":"368_CR10","first-page":"464","volume":"55","author":"K Waurick","year":"2014","unstructured":"Waurick K, Riess H (2014) 3. \u00fcberarbeitete Empfehlung der Deutschen Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin \u2013 S1-Leitlinie: R\u00fcckenmarksnahe Regionalan\u00e4sthesien und Thrombembolieprophylaxe\/antithrombotische Medikation. An\u00e4sth Intensivmed 55:464\u2013492","journal-title":"An\u00e4sth Intensivmed"},{"issue":"2 Suppl","key":"368_CR11","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH et al (2012) Perioperative management of antithrombotic therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based linical practice guidelines. Chest 141(2 Suppl):e326S\u2013e350S","journal-title":"Chest"},{"issue":"4","key":"368_CR12","first-page":"346","volume":"13","author":"B Sporbeck","year":"2015","unstructured":"Sporbeck B, Georges Bechara F, H\u00e4fner H\u2011M, Koenen W, Kolk A, Koscielny J et al (2015) S3 guidelines for the management of anticoagulation in cutaneous surgery. J Dtsch Dermatol Ges 13(4):346\u2013356","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"368_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12181-010-0294-y","volume":"4","author":"HM Hoffmeister","year":"2010","unstructured":"Hoffmeister HM, Bode C, Darius H, Huber K, Rybak K, Silber S (2010) Positionspapier Unterbrechung antithrombotischer Behandlung (Bridging) bei kardialen Erkrankungen. Kardiologe 4(5):365\u2013374","journal-title":"Kardiologe"},{"key":"368_CR14","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1378\/chest.08-0675","volume":"133","author":"JD Douketis","year":"2008","unstructured":"Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC et al (2008) The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:299S\u2013339S","journal-title":"Chest"},{"issue":"21","key":"368_CR15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"2;64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC et\u00a0al (2014) 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J\u00a0Am Coll Cardiol 2;64(21):e1\u201376","journal-title":"J. Am. Coll. Cardiol."},{"key":"368_CR16","unstructured":"Mainz A (2013) DEGAM S1-Handlungsempfehlung Bridging, AWMF. Registrierungsnummer: 053\u2013027"},{"issue":"7","key":"368_CR17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jamainternmed.2015.1858","volume":"175","author":"DJ Brotman","year":"2015","unstructured":"Brotman DJ, Streiff MB (2015) Overuse of bridging anticoagulation for patients with venous thromboembolism: First, do no harm. JAMA Intern Med 175(7):1169\u20131170","journal-title":"JAMA Intern Med"},{"issue":"5","key":"368_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.114.014319","volume":"131","author":"AY Shaikh","year":"2015","unstructured":"Shaikh AY, McManus DD (2015) A bridge too far? Findings of bridging anticoagulation use and outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circulation 131(5):448\u2013450","journal-title":"Circulation"},{"issue":"5","key":"368_CR19","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1378\/chest.116.5.1240","volume":"116","author":"JD Douketis","year":"1999","unstructured":"Douketis JD, Crowther MA, Cherian SS, Kearon CB (1999) Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 116(5):1240\u20131246","journal-title":"Chest"},{"issue":"13","key":"368_CR20","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","volume":"126","author":"D Siegal","year":"2012","unstructured":"Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC (2012) Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 126(13):1630\u20131639","journal-title":"Circulation"},{"issue":"22","key":"368_CR21","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","volume":"368","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD et\u00a0al (2013) Pacemaker or defibrillator surgery without interruption of anticoagulation. N\u00a0Engl J Med 368(22):2084\u20132093","journal-title":"N. Engl. J. Med."},{"key":"368_CR22","unstructured":"Mainz A (2013) DEGAM S1-Handlungsempfehlung Bridging"},{"issue":"12","key":"368_CR23","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jacc.2015.08.002","volume":"66","author":"SJ Rechenmacher","year":"2015","unstructured":"Rechenmacher SJ, Fang JC (2015) Bridging anticoagulation: Primum non nocere. J\u00a0Am Coll Cardiol 66(12):1392\u20131403","journal-title":"J. Am. Coll. Cardiol."},{"key":"368_CR24","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-47186-9","volume-title":"Arzneiverordnungs-Report 2015: Aktuelle Daten, Kosten, Trends und Kommentare","author":"U Schwabe","year":"2015","unstructured":"Schwabe U, Paffarth D (2015) Arzneiverordnungs-Report 2015: Aktuelle Daten, Kosten, Trends und Kommentare. Springer, Heidelberg, Berlin, New York"},{"key":"368_CR25","unstructured":"Lawson. PERIOP 2 \u2013 A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin. NCT 00432796"},{"issue":"5","key":"368_CR26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.114.011777","volume":"131","author":"BA Steinberg","year":"2015","unstructured":"Steinberg BA, Peterson ED, Kim S, Thomas L, Gersh BJ, Fonarow GC et al (2015) Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circulation 131(5):488\u2013494","journal-title":"Circulation"},{"issue":"22","key":"368_CR27","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/CIRCULATIONAHA.108.823211","volume":"119","author":"V Pengo","year":"2009","unstructured":"Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L et al (2009) Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: An inception cohort management study. Circulation 119(22):2920\u20132927","journal-title":"Circulation"},{"issue":"11","key":"368_CR28","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1538-7836.2007.02729.x","volume":"5","author":"AS Dunn","year":"2007","unstructured":"Dunn AS, Spyropoulos AC, Turpie AGG (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: The Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J\u00a0Thromb Haemost 5(11):2211\u20132218","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"368_CR29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","volume":"373","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS et\u00a0al (2015) Perioperative bridging anticoagulation in patients with atrial fibrillation. N\u00a0Engl J Med 373(9):823\u2013833","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"368_CR30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2012.04630.x","volume":"10","author":"AC Spyropoulos","year":"2012","unstructured":"Spyropoulos AC, Douketis JD, Gerotziafas G, Kaatz S, Ortel TL, Schulman S et\u00a0al (2012) Periprocedural antithrombotic and bridging therapy: Recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. J\u00a0Thromb Haemost 10(4):692\u2013694","journal-title":"J. Thromb. Haemost."},{"key":"368_CR31","unstructured":"von Heymann C, Koscielny J (2016) Update: Patienten unter oraler Antikoagulation mit VKA oder NOAK \u2013 Perioperatives \u201eBridging\u201c oder \u201eSwitching?\u201c. An\u00e4sth Intensivmed 57:316\u2013331"},{"key":"368_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12181-010-0294-y","volume":"4","author":"H Hoffmeister","year":"2010","unstructured":"Hoffmeister H, Bode C, Darius H, Huber K, Rybak K, Silber S (2010) Unterbrechung antithrombotischer Behandlung (Bridging) bei kardialen Erkrankungen. Kardiologe 4:365\u2013374","journal-title":"Kardiologe"},{"issue":"3","key":"368_CR33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1742-1241.2010.02538.x","volume":"65","author":"GYH Lip","year":"2011","unstructured":"Lip GYH, Durrani OM, Roldan V, Lip PL, Marin\u00a0F, Reuser TQ (2011) Peri-operative management of ophthalmic patients taking antithrombotic therapy. Int J Clin Pract 65(3):361\u2013371","journal-title":"Int. J. Clin. Pract."},{"issue":"5","key":"368_CR34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bjh.12644","volume":"164","author":"JP Patel","year":"2014","unstructured":"Patel JP, Arya R (2014) The current status of bridging anticoagulation. Br J Haematol 164(5):619\u2013629","journal-title":"Br. J. Haematol."},{"issue":"Suppl 1","key":"368_CR35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/anae.12900","volume":"70","author":"JJ Veen Van","year":"2015","unstructured":"Van Veen JJ, Makris M (2015) Management of peri-operative anti-thrombotic therapy. Anaesthesia 70(Suppl 1):58\u201367 (e21\u20133)","journal-title":"Anaesthesia"},{"key":"368_CR36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH02-10-0159","volume":"90","author":"H Omran","year":"2003","unstructured":"Omran H, Hammerstingl C, Schmidt H, von der Recke G, Paar WD, Luderitz B (2003) A prospective and randomized comparison of the safety and effects of therapeutic levels of enoxaparin versus unfractionated heparin in chronically anticoagulated patients undergoing elective cardiac catheterization. Thromb Haemost 90:267\u2013271","journal-title":"Thromb. Haemost."},{"issue":"12","key":"368_CR37","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1538-7836.2005.01674.x","volume":"3","author":"KM Halbritter","year":"2005","unstructured":"Halbritter KM, Wawer A, Beyer J, Oettler W, Schellong SM (2005) Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes. J\u00a0Thromb Haemost 3(12):2823\u20132825","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"368_CR38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1755-5922.2009.00099.x","volume":"27","author":"C Hammerstingl","year":"2009","unstructured":"Hammerstingl C, Schmitz A, Fimmers R, Omran H (2009) Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: Results from the prospective BRAVE registry. Cardiovasc Ther 27(4):230\u2013238","journal-title":"Cardiovasc Ther"},{"key":"368_CR39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00063-007-1098-0","volume":"102","author":"H Omran","year":"2007","unstructured":"Omran H, Hammerstingl C, Paar WD (2007) Perioperative bridging with Enoxaparin. Results of the prospective BRAVE registry with 779 patients. Perioperative \u00fcberbr\u00fcckende Antikoagulation mit Enoxaparin. Ergebnisse des prospektiven BRAVE-registers mit 779 Patienten. Med Klin 102:809\u2013815","journal-title":"Med Klin"},{"issue":"1","key":"368_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH11-12-0827","volume":"108","author":"H Omran","year":"2012","unstructured":"Omran H, Bauersachs R, R\u00fcbenacker S, Goss F, Hammerstingl C (2012) The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Thromb Haemost 108(1):65\u201373","journal-title":"Thromb. Haemost."},{"issue":"1","key":"368_CR41","doi-asserted-by":"crossref","first-page":"e000067","DOI":"10.1161\/JAHA.112.000067","volume":"2","author":"DE Singer","year":"2013","unstructured":"Singer DE, Hellkamp AS, Piccini JP, Mahaffey KW, Lokhnygina Y, Pan G et\u00a0al (2013) Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: Data from the ROCKET AF clinical trial. J\u00a0Am Heart Assoc 2(1):e000067","journal-title":"J Am Heart Assoc"},{"issue":"8607","key":"368_CR42","first-page":"349","volume":"2","author":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","year":"1988","unstructured":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2(8607):349\u2013360","journal-title":"Lancet"},{"issue":"3","key":"368_CR43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet J\u2011P, Mueller C, Valgimigli M, Andreotti F et al (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267\u2013315","journal-title":"Eur. Heart J."},{"issue":"20","key":"368_CR44","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Task Force on the Management of ST-segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Bl\u00f6mstrom-Lundqvist C et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569\u20132619","journal-title":"Eur. Heart J."},{"issue":"12","key":"368_CR45","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","volume":"304","author":"DL Bhatt","year":"2010","unstructured":"Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM et al (2010) Comparative determinants of 4\u2011year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 304(12):1350\u20131357","journal-title":"JAMA"},{"issue":"2","key":"368_CR46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.amjcard.2013.08.039","volume":"113","author":"WJ Kikkert","year":"2014","unstructured":"Kikkert WJ, Hoebers LP, Damman P, Lieve KVV, Claessen BEPM, Vis MM et al (2014) Recurrent myocardial infarction after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 113(2):229\u2013235","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"368_CR47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1253\/circj.CJ-11-1059","volume":"77","author":"D Nakatani","year":"2013","unstructured":"Nakatani D, Sakata Y, Suna S, Usami M, Matsumoto S, Shimizu M et\u00a0al (2013) Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction. Circ J 77(2):439\u2013446","journal-title":"Circ. J."},{"issue":"8","key":"368_CR48","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s00125-010-1783-z","volume":"53","author":"ML Norgaard","year":"2010","unstructured":"Norgaard ML, Andersen SS, Schramm TK, Folke F, J\u00f8rgensen CH, Hansen ML et al (2010) Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction \u2013 a nationwide study. Diabetologia 53(8):1612\u20131619","journal-title":"Diabetologia"},{"issue":"4","key":"368_CR49","first-page":"390","volume":"37","author":"JA Udell","year":"2016","unstructured":"Udell JA, Bonaca MP, Collet J\u2011P, Lincoff AM, Kereiakes DJ, Costa F et al (2016) Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: A collaborative meta-analysis of randomized trials. Eur Heart J 37(4):390\u2013399","journal-title":"Eur. Heart J."},{"issue":"8","key":"368_CR50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJMoa1507688","volume":"374","author":"PS Myles","year":"2016","unstructured":"Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T et\u00a0al (2016) Stopping vs. continuing Aspirin before coronary artery surgery. N\u00a0Engl J Med 374(8):728\u2013737","journal-title":"N. Engl. J. Med."},{"issue":"31-32","key":"368_CR51","first-page":"525","volume":"110","author":"A Schlitt","year":"2013","unstructured":"Schlitt A, J\u00e1mbor C, Spannagl M, Gogarten W, Schilling T, Zwissler B (2013) The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors. Dtsch Arztebl Int 110(31-32):525\u2013532","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"368_CR52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2796.2005.01477.x","volume":"257","author":"W Burger","year":"2005","unstructured":"Burger W, Chemnitius J\u2011M, Kneissl GD, R\u00fccker G (2005) Low-dose aspirin for secondary cardiovascular prevention \u2013 cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation \u2013 review and meta-analysis. J\u00a0Intern Med 257(5):399\u2013414","journal-title":"J. Intern. Med."},{"key":"368_CR53","doi-asserted-by":"crossref","unstructured":"Kumar N, Jivan S, Thomas P, McLure H (2006) Sub-Tenon\u2019s anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 32(6):1022\u20131025","DOI":"10.1016\/j.jcrs.2006.02.035"},{"issue":"5","key":"368_CR54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archopht.116.5.571","volume":"116","author":"QH Nguyen","year":"1998","unstructured":"Nguyen QH, Budenz DL, Parrish RK (1998) Complications of Baerveldt glaucoma drainage implants. Arch Ophthalmol 116(5):571\u2013575","journal-title":"Arch. Ophthalmol."},{"key":"368_CR55","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.eye.6702277","volume":"21","author":"CJ Cobb","year":"2007","unstructured":"Cobb CJ, Chakrabarti S, Chadha V, Sanders R (2007) The effect of aspirin and warfarin therapy in trabeculectomy. Eye (Lond) 21:598\u2013603","journal-title":"Eye (Lond)"},{"issue":"4","key":"368_CR56","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ajo.2007.12.007","volume":"145","author":"SK Law","year":"2008","unstructured":"Law SK, Song BJ, Yu F, Kurbanyan K, Yang T\u2011A, Caprioli J (2008) Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy. Am J Ophthalmol 145(4):736\u2013746","journal-title":"Am. J. Ophthalmol."},{"issue":"9","key":"368_CR57","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0161-6420(03)00785-1","volume":"110","author":"J Katz","year":"2003","unstructured":"Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG et\u00a0al (2003) Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 110(9):1784\u20131788","journal-title":"Ophthalmology"},{"issue":"9","key":"368_CR58","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/IAE.0b013e31825097ae","volume":"32","author":"M Passemard","year":"2012","unstructured":"Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C (2012) Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery. Retina (Pphiladelphia Pa) 32(9):1868\u20131873","journal-title":"Retina (Pphiladelphia Pa)"},{"key":"368_CR59","doi-asserted-by":"publisher","unstructured":"Fabinyi DC, O\u2019Neill EC, Connell PP, Clark JB (2011) Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents. Clin Exp Ophthalmol 39(9):878\u2013884. doi: 10.1111\/j.1442-9071.2011.02575.x","DOI":"10.1111\/j.1442-9071.2011.02575.x"},{"issue":"4","key":"368_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2012.11.004","volume":"155","author":"MK Khuthaila","year":"2013","unstructured":"Khuthaila MK, Hsu J, Chiang A, DeCroos FC, Milder EA, Setlur V et al (2013) Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol 155(4):1\u20132","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"368_CR61","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ajo.2010.09.035","volume":"151","author":"J Oh","year":"2011","unstructured":"Oh J, Smiddy WE, Kim SS (2011) Antiplatelet and anticoagulation therapy in vitreoretinal surgery. Am J Ophthalmol 151(6):934\u2013939.e3","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"368_CR62","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/bjo.2010.187526","volume":"95","author":"A Chandra","year":"2011","unstructured":"Chandra A, Jazayeri F, Williamson TH (2011) Warfarin in vitreoretinal surgery: A case controlled series. Br J Ophthalmol 95(7):976\u2013978","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"368_CR63","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/IAE.0b013e31821800cd","volume":"31","author":"JS Brown","year":"2011","unstructured":"Brown JS, Mahmoud TH (2011) Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina (Philadelphia Pa) 31(10):1983\u20131987 (Nov)","journal-title":"Retina (Philadelphia Pa)"},{"issue":"3","key":"368_CR64","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ophtha.2010.07.005","volume":"118","author":"JO Mason 3rd","year":"2011","unstructured":"Mason JO 3rd, Gupta SR, Compton CJ, Frederick PA, Neimkin MG, Hill ML et al (2011) Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group. Ophthalmology 118(3):543\u2013547","journal-title":"Ophthalmology"},{"issue":"4","key":"368_CR65","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bjo.2003.026179","volume":"88","author":"R Ling","year":"2004","unstructured":"Ling R, Kamalarajah S, Cole M, James C, Shaw S (2004) Suprachoroidal haemorrhage complicating cataract surgery in the UK: A case control study of risk factors. Br J Ophthalmol 88(4):474\u2013477","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"368_CR66","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-2005-858231","volume":"222","author":"GB Jaissle","year":"2005","unstructured":"Jaissle GB, Szurman P, Bartz-Schmidt KU (2005) Recommendation for the implementation of intravitreal injections \u2013 statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monbl Augenheilkd 222(5):390\u2013395","journal-title":"Klin Monbl Augenheilkd"},{"issue":"1","key":"368_CR67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/bjh.12107","volume":"160","author":"M Makris","year":"2013","unstructured":"Makris M, Van Veen JJ, Tait CR, Mumford AD, Laffan M, British Committee for Standards in Haematology (2013) Guideline on the management of bleeding in patients on antithrombotic agents. Br J Haematol 160(1):35\u201346","journal-title":"Br. J. Haematol."},{"issue":"25","key":"368_CR68","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","volume":"120","author":"PA Gurbel","year":"2009","unstructured":"Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C et al (2009) Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET\/OFFSET study. Circulation 120(25):2577\u20132585","journal-title":"Circulation"},{"issue":"4","key":"368_CR69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5482\/ha-2012030001","volume":"32","author":"J Koscielny","year":"2012","unstructured":"Koscielny J, Beyer-Westendorf J, von Heymann C, Braun J, Klamroth R, Lindhoff-Last E et al (2012) Risk of bleeding and haemorrhagic complication with rivaroxaban \u2013 periprocedural management of haemostasis. Hamostaseologie 32(4):287\u2013293","journal-title":"Hamostaseologie"},{"issue":"4","key":"368_CR70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5482\/ha-2012030004","volume":"32","author":"M Spannagl","year":"2012","unstructured":"Spannagl M, Bauersachs R, Debus ES, Gawaz M, Gerlach H, Haas S et\u00a0al (2012) Dabigatran therapy \u2013 perioperative management and interpretation of coagulation tests. Hamostaseologie 32(4):294\u2013305","journal-title":"Hamostaseologie"},{"issue":"8","key":"368_CR71","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/archopht.118.8.1037","volume":"118","author":"PC Jacobi","year":"2000","unstructured":"Jacobi PC, Dietlein TS, Jacobi FK (2000) A comparative study of topical vs retrobulbar anesthesia in complicated cataract surgery. Arch Ophthalmol 118(8):1037\u20131043","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"368_CR72","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/ALN.0b013e3181f7a78e","volume":"113","author":"E Nouvellon","year":"2010","unstructured":"Nouvellon E, Cuvillon P, Ripart J (2010) Regional anesthesia and eye surgery. Anesthesiology 113(5):1236\u20131242","journal-title":"Anesthesiology"},{"key":"368_CR73","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00417-011-1783-9","volume":"249","author":"C Tappeiner","year":"2011","unstructured":"Tappeiner C, Garweg JG (2011) Retinal vascular occlusion after vitrectomy with retrobulbar anesthesia-observational case series and survey of literature. Graefes Arch Clin Exp Ophthalmol 249:1831\u20131835","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"5-6","key":"368_CR74","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08820538.2014.959191","volume":"29","author":"A Gross","year":"2014","unstructured":"Gross A, Cestari DM (2014) Optic neuropathy following retrobulbar injection: A review. Semin Ophthalmol 29(5-6):434\u2013439","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"368_CR75","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00417-008-0792-9","volume":"246","author":"A Alwitry","year":"2008","unstructured":"Alwitry A, King AJ, Vernon SA (2008) Anticoagulation therapy in glaucoma surgery. Graefes Arch Clin Exp Ophthalmol 246(6):891\u2013896","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"10","key":"368_CR76","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/bjophthalmol-2014-304902","volume":"98","author":"CA Kiire","year":"2014","unstructured":"Kiire CA, Mukherjee R, Ruparelia N, Keeling D, Prendergast B, Norris JH (2014) Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Br J Ophthalmol 98(10):1320\u20131324","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"368_CR77","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/ICO.0b013e318201255a","volume":"30","author":"SB Koenig","year":"2011","unstructured":"Koenig SB (2011) Delayed massive suprachoroidal hemorrhage after descemet stripping automated endothelial keratoplasty. Cornea 30(7):818\u2013819","journal-title":"Cornea"},{"issue":"3","key":"368_CR78","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jaad.2011.02.012","volume":"65","author":"JS Bordeaux","year":"2011","unstructured":"Bordeaux JS, Martires KJ, Goldberg D, Pattee SF, Fu P, Maloney ME (2011) Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications. J\u00a0Am Acad Dermatol 65(3):576\u2013583","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"368_CR79","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaad.2011.02.013","volume":"65","author":"RH Cook-Norris","year":"2011","unstructured":"Cook-Norris RH, Michaels JD, Weaver AL, Phillips PK, Brewer JD, Roenigk RK et al (2011) Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation. J Am Acad Dermatol 65(3):584\u2013591","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"368_CR80","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00042728-200802000-00004","volume":"34","author":"KG Lewis","year":"2008","unstructured":"Lewis KG, Dufresne RG (2008) A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery. Dermatol Surg 34(2):160\u2013164 (discussion 164\u2013165)","journal-title":"Dermatol Surg"},{"issue":"6","key":"368_CR81","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00002341-200211000-00004","volume":"18","author":"PL Custer","year":"2002","unstructured":"Custer PL, Trinkaus KM (2002) Hemorrhagic complications of oculoplastic surgery. Ophthal Plast Reconstr Surg 18(6):409\u2013415","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"368_CR82","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2147\/OPTH.S19455","volume":"5","author":"R Karim","year":"2011","unstructured":"Karim R, Ghabrial R, Lynch T, Tang B (2011) A comparison of external and endoscopic endonasal dacryocystorhinostomy for acquired nasolacrimal duct obstruction. Clin Ophthalmol 5:979\u2013989","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"368_CR83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0033-1333838","volume":"29","author":"AM Terella","year":"2013","unstructured":"Terella AM, Wang TD, Kim MM (2013) Complications in periorbital surgery. Facial Plast Surg 29(1):64\u201370","journal-title":"Facial Plast Surg"},{"issue":"2","key":"368_CR84","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/IOP.0b013e31827f599e","volume":"29","author":"TL Kent","year":"2013","unstructured":"Kent TL, Custer PL (2013) Bleeding complications in both anticoagulated and nonanticoagulated surgical patients. Ophthal Plast Reconstr Surg 29(2):113\u2013117","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"8","key":"368_CR85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/EJA.0b013e328360c442","volume":"30","author":"F Bonhomme","year":"2013","unstructured":"Bonhomme F, Hafezi F, Boehlen F, Habre W (2013) Management of antithrombotic therapies in patients scheduled for eye surgery. Eur J Anaesthesiol 30(8):449\u2013454","journal-title":"Eur J Anaesthesiol"},{"key":"368_CR86","unstructured":"Nast A (2014) S3-Leitlinie: Umgang mit Antikoagulation bei Operationen an der Haut AWMF-Register-Nummer 013-085"},{"key":"368_CR87","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00347-009-2088-9","volume":"107","author":"N Feltgen","year":"2010","unstructured":"Feltgen N, Pielen A, Hattenbach LO, Geisen U, Heinz J (2010) Perioperative conversion of oral anticoagulants to heparin (bridging) in ophthalmic medicine. Ophthalmologe 107:636\u2013640","journal-title":"Ophthalmologe"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-016-0368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-016-0368-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-016-0368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T20:33:15Z","timestamp":1568406795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-016-0368-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,26]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1007\/s00347-016-0368-8","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,26]]}}}